Denise Neves Gameiro, Author at Labiotech.eu

About

Journalist intern. Studied Bioengineering in Porto and was a lab rat in Sweden. Enjoying Berlin and the company of Labiotech’s resident plants.

Articles by Denise Neves Gameiro

News and Trends 26 Feb 2016

A New Super-Antibody against Ebola has been Isolated

Humabs BioMed (Switzerland), in collaboration with institutional partners has succeeded in isolating new antibodies against the Ebola virus and turned them into a potential therapy against it. Humabs discovers monoclonal antibodies by doing blood analysis of survivors to given infectious diseases. For example, if one wants the cure for the flu, it looks into people […]

February 26, 2016 - 3 minutesmins - By Denise Neves Gameiro

suzanne ankler bioart zoosemiotics MRI butterfly vanitas petri remote sensing 3D print rainbow loom

News and Trends 26 Feb 2016

Faces of Bioart: Depicting the Psychology of Petri Dishes and Chromosomes with Suzanne Anker

Suzanne Anker is a must-know in the BioArt community, with expositions around the world and directing her own BioArt lab in New York. She explores artefacts that have become icons of Biology – such as chromosomes, MRI scans and Petri dishes. Around the same time the Human Genome Project was initiated, Anker exhibited Zoosemiotics (1993). […]

February 26, 2016 - 4 minutesmins - By Denise Neves Gameiro

News and Trends 25 Feb 2016

NGS Battle: Illumina is now suing Oxford Nanopore (and it looks suspicious)

NGS-Giant Illumina (US) is suing Oxford Nanopore (UK), the Unicorn ready to disrupt gene sequencing. What’s the story? Illumina currently has the monopoly on NGS equipment, and Illumina’s machines make a common (and bulky) fixture in labs all over the world. In the future, many hospitals will move into data-driven medicine and NGS plays an important […]

February 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

nestle health sciences pronutria investment amino acids food

News and Trends 25 Feb 2016

Boston Food Biotech Gets €38M from Nestlé

Pronutria (US) is a start-up out of Flagship Ventures developing nutritional therapies which has now gotten a huge equity investment from Nestlé Health Science (Switzerland). Pronutria is a cool Biotech start-up taking an innovative approach to treat diseases caused by amino acid imbalance, such as muscle loss, and neurological and liver complications. Besides being essential for protein synthesis, […]

February 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 24 Feb 2016

German Biotech wins FDA Approval for New Liver Cancer Trial

4SC, in Germany, has the FDA’s green light to conduct efficacy trials in the US with a candidate drug against hepatocellular carcinoma. Munich-based 4SC’s lead candidate, resminostat, is a small-molecule being tested in several trials for some of the deadliest cancers. These include liver – which is also known as hepatocellular carcinoma (HCC). Resminostat is an inhibitor of histone […]

February 24, 2016 - 3 minutesmins - By Denise Neves Gameiro

microbiome lyon czech mouse igf1 growth research

News and Trends 24 Feb 2016

Your Microbiome even Impacts how Tall you are!

Research at the University of Lyon (France) and Czech Academy of Sciences have found a previously unknown link between the microbiome and Human growth, as well as a potential therapeutic application for Lactobacillus plantarum. The microbiome is a hot field for research and Health Biotechs alike, and Europe is home to some of the leaders in […]

February 24, 2016 - 3 minutesmins - By Denise Neves Gameiro

gilead hiv aids grant retroviral truvada

News and Trends 23 Feb 2016

How could the HIV Field benefit from Gilead’s new €2M Research Grants?

The US Giant Gilead is opening a new program of Grants to fund the next generation of HIV research for 3-years. Targets are academic institutions and non-profit organization. HIV remains a global health challenge, with around 37 million people infected in the world. The rate of new infections fell in the last decades, but it is […]

February 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

desktop genetics gene ngs illumina epigenetics

News and Trends 23 Feb 2016

UK Start-Up Gets €380k to Understand Cancer with CRISPR

Desktop Genetics, a small bioinformatics start-up out of London, has won a substantial grant to understand why some cancer cells just won’t quit. To do this, it relies on CRISPR, their expertise with genetic data, and research from Imperial College London. Desktop Genetics has already proven that it can move some money, with a €1.87 […]

February 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

paion surgery Remimazolam cardiac colonoscopy praion

News and Trends 22 Feb 2016

This German Biotech had to stop its EU Phase III Trial for Lack of Recruitment

The Aachen-based pharma Paion (Germany), has been forced to axe a European phase III trial for a Surgical sedative, after failing to recruit enough patients. The company will instead focus its efforts on its ongoing US trials. This is a blow to Paion’s pipeline, which is led by Remimazolam. The company stock price decreased almost 40%, but it […]

February 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

osteoporosis vertebral column denosumab amgen ucb

News and Trends 22 Feb 2016

Can this Positive Phase III Immunotherapy End Spinal Fractures due to Osteoporosis?

UCB (Belgium) has a monoclonal antibody candidate (romozumab) which has met its primary endpoints for a phase III Osteoporosis trial, FRAME in partnership with Amgen. The drug showed 75% improvement (compared to placebo) and few side effects. UCB in Brussels is developing immunotherapies for a range of chronic diseases, which has now gotten good phase III results for an […]

February 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

bone therapeutics allob preob spine therapy medtech

News and Trends 18 Feb 2016

This Bone Cell Therapy Could Make it to a Shelf Near You

Bone Therapeutics (Belgium) is almost finished with the phase IIa trial for a Spinal cell therapy. The 12 people treated for degenerative bone conditions show no complications – a gold star for the safety check of this off-the-shelf product. This Belgian biotech is developing two different osteoblastic cell therapies, PREOB and ALLOB, to treat a variety of […]

February 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

jens nielsen novozymes chalmers nordisk novo cell factories

News and Trends 18 Feb 2016

This Pioneering Systems Biology Professor Received a €400K Prize from Novozymes

Jens Nielsen pioneered Systems Biology in Europe. His research efforts focus on transferring science research to industrial applications – to create a society independent of fossil fuels. He has now been awarded Novozymes Prize. Nielsen, a professor at Chalmers University of Technology in Gothenburg (Sweden), literally co-wrote the book on Metabolic Engineering back in 1998. During this period he […]

February 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Denise Neves Gameiro

About

Articles by Denise Neves Gameiro

A New Super-Antibody against Ebola has been Isolated

Faces of Bioart: Depicting the Psychology of Petri Dishes and Chromosomes with Suzanne Anker

NGS Battle: Illumina is now suing Oxford Nanopore (and it looks suspicious)

Boston Food Biotech Gets €38M from Nestlé

German Biotech wins FDA Approval for New Liver Cancer Trial

Your Microbiome even Impacts how Tall you are!

How could the HIV Field benefit from Gilead’s new €2M Research Grants?

UK Start-Up Gets €380k to Understand Cancer with CRISPR

This German Biotech had to stop its EU Phase III Trial for Lack of Recruitment

Can this Positive Phase III Immunotherapy End Spinal Fractures due to Osteoporosis?

This Bone Cell Therapy Could Make it to a Shelf Near You

This Pioneering Systems Biology Professor Received a €400K Prize from Novozymes

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Denise Neves Gameiro

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!